CDK4 and breast carcinoma: The same trend of the result was also demonstrated in HT29 colorectal cancer cells, MCF-7 breast cancer cells, and human ovarian cancer cells with downregulation of cyclin D1 and CDK4 (Banafa et al., 2013; Han et al., 2015; Liu et al., 2020).